HLN

Haleon plc
NYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$42.19B
P/E Ratio
19.55
EPS
$0.49
Beta
0.24
52W High
$11.06
52W Low
$8.54
50-Day MA
$9.59
200-Day MA
$9.81
Dividend Yield
2.04%
Profit Margin
14.50%
Forward P/E
17.54
PEG Ratio
2.40

About Haleon plc

Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline, dedicated to providing innovative health solutions through a robust portfolio of trusted brands, including Sensodyne, Panadol, and Voltaren. Focused on key segments such as oral care, pain relief, and dietary supplements, Haleon addresses evolving consumer needs while leveraging strong brand equity for sustained market presence. The company's commitment to sustainability and ongoing innovation, alongside strategic investments in product development, positions Haleon favorably for long-term growth and enhanced health outcomes, ultimately maximizing value for shareholders.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$11.15B
Gross Profit (TTM)$7.31B
EBITDA$2.85B
Operating Margin23.90%
Return on Equity10.10%
Return on Assets5.08%
Revenue/Share (TTM)$2.50
Book Value$4.99
Price-to-Book1.93
Price-to-Sales (TTM)3.78
EV/Revenue3.472
EV/EBITDA13.78
Quarterly Earnings Growth (YoY)-4.50%
Quarterly Revenue Growth (YoY)2.20%
Shares Outstanding$4.40B
Float$4.43B
% Insiders0.01%
% Institutions13.52%

Historical Volatility

HV 10-Day
14.80%
HV 20-Day
21.28%
HV 30-Day
21.90%
HV 60-Day
24.63%
HV Rank
59.1%

Volatility is currently contracting

Analyst Ratings

Consensus ($11.99 target)
2
Strong Buy
1
Buy
2
Hold

Latest News

Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes

LONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the "Offeror") is offering to buy back any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. Bondholders will receive a price equal to the Total Consideration based on the Reference Yield and the Fixed Spread plus Accrued Interest (each as defined below) (the "Tender Offer").

PRNewsWire8/11/2026Neutral
ACCO vs. HLN: Which Stock Is the Better Value Option?

Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Acco Brands (ACCO) and Haleon PLC Sponsored ADR (HLN). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research8/4/2026Positive
Haleon slides as quality of growth questioned

Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 2.9% to 368.7p after the consumer healthcare group reported improving second-quarter sales but left its full-year guidance unchanged. Organic revenue increased 3.1% in the second quarter, split between 1.7% from pricing and 1.4% from volumes and product mix.

Proactive Investors7/30/2026Negative
FTSE 100 shares to watch: Lloyds, Barclays, IAG, NatWest, GSK, AstraZeneca

The FTSE 100 Index was little changed this week as investors assessed the escalating UK-Iran crisis, the ongoing US earnings season, and a series of key UK economic releases. Market participants digested the latest jobs, inflation, and retail sales data for July, all of which could influence the Bank of England's next policy decision.

Invezz7/24/2026Neutral
LCUT vs. HLN: Which Stock Is the Better Value Option?

Investors interested in stocks from the Consumer Products - Discretionary sector have probably already heard of Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research7/1/2026Neutral
Haleon to Accelerate AI-powered Transformation With New Five-year Microsoft Collaboration

LONDON--(BUSINESS WIRE)-- #AI--Haleon, a consumer health company solely focused on better everyday health, today announces a new five-year collaboration with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global Win as One strategy. The new agreement builds on Haleon's existing use of Microsoft 365 Copilot and further supports the wider adoption of AI-powered tools across the business, helping teams automate routine tasks, collaborate more effe.

Business Wire7/1/2026Neutral
Futura swaps Haleon for Market Performance Group to drive US Eroxon sales

Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has ended its US partnership with consumer health giant Haleon PLC (LSE:HLN, NYSE:HLN) and lined up a new distributor for its erectile dysfunction treatment Eroxon. The group, which specialises in clinically proven sexual health products, has signed a distribution agreement with Market Performance Group, a US omnichannel commerce agency.

Proactive Investors6/29/2026Negative
LCUT or HLN: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Consumer Products - Discretionary sector might want to consider either Lifetime Brands (LCUT) or Haleon PLC Sponsored ADR (HLN). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research6/15/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HLN and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026